ARCHIVES

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

This article is from The Cancer Letter archive.

Vol. 02 No. 14 | April 2, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

DCE Advisors Approve New Grant Program On Lung Carcinoma

June 30, 1995

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974